TICKERNERD
Menu
ALPSALPS

ALPS Stock Forecast: Alps Group, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$0.32
−2.44% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 22 of 100 as at 14 Aug 2026 — in the weakest quartile.

Market cap
$54.6M
Ticker Nerd rank
22 / 100
Median analyst target
—
Analysts covering
—
Total return, dividends reinvested
1W
−22.9%
1M
−32.9%
YTD
−63.2%
From high
−87.5%
From low
0.0%
$0.32
$2.56
Range since 31 Oct 2025, adjusted closes · the dot is the last close
Ticker Nerd rank

ALPS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Alps Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Aug 2026
22 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
88
Size
82
Issuance
48
Volatility
36
Growth
28
Value
28
Revisions
25
Momentum
14
Quality
11

Accruals (88): Reported profit is backed by cash, and the company is not expanding recklessly.

Quality (11): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ALPS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ALPS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, since 31 Oct 2025Adjusted close, US dollars
$0.00$0.50$1.00$1.50$2.00$2.50Jan 26Apr 26Jul 26ALPS

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALPS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ALPS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Alps Group, Inc. (ALPS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.2×

Cheaper than 72% of US stocks

Price / sales
11.2×

Cheaper than 14% of US stocks

Price / book
−3.4×

Cheaper than 96% of US stocks

EV / EBITDA
−35.1×

Cheaper than 92% of US stocks

Growth & margins
Revenue growth (YoY)
−519.3%

Higher than 1% of US stocks

Earnings growth (YoY)
—
Gross margin
5.5%

Higher than 7% of US stocks

Operating margin
−41.8%

Higher than 18% of US stocks

Net margin
32.1%

Higher than 91% of US stocks

Returns & dividend
Return on equity
62.2%

Higher than 94% of US stocks

Return on assets
−28.8%

Higher than 15% of US stocks

Dividend yield
120.5%

Higher than 98% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ALPS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Alps Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ALPS news & analysis

Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update

GlobeNewsWire · 7 Aug 2026positive

Alps Group Inc reported fiscal year 2026 financial results, with revenue growing 44% to $4.9 million, driven by growth across its cellular therapy, medical testing, laboratory, aesthetics beauty services, and healthcare products segments.

Why it matters — The strong revenue growth signals expanding business activity across multiple service and product lines, which would be of interest to shareholders tracking the company's operational progress.

ALPS Ties Fund Growth to Distribution Discipline

ETF Trends · 24 July 2026positive

ALPS, operating with a lean distribution team compared to larger ETF issuers, is tying new fund launches to disciplined distribution choices to ensure each product earns its place on the shelf. The firm's $22 billion lineup requires deliberate, strategic decisions about which new ETFs to bring to market.

Why it matters — For ALPS watchers, this distribution-discipline approach signals a prudent growth strategy that prioritizes quality over scale, potentially supporting long-term fund performance and shelf-space viability.

FAQ

Frequently asked questions about ALPS stock

How does Ticker Nerd's model rank ALPS?

As at 14 Aug 2026, Alps Group, Inc. ranks 22 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (88 of 100).

What is the ALPS stock forecast for 2030?

No analyst covering Alps Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALPS are extrapolating price history, which says nothing about the business.

What does Alps Group, Inc. do?

Alps Group Inc. is a biotechnology and life sciences company headquartered in Kuala Lumpur, Malaysia.

What is the latest news on ALPS?

The most recent item we track (GlobeNewsWire, 7 Aug 2026): "Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update". Alps Group Inc reported fiscal year 2026 financial results, with revenue growing 44% to $4.9 million, driven by growth across its cellular therapy, medical testing, laboratory, aesthetics beauty services, and healthcare products segments.

Company

About Alps Group, Inc.

Alps Group Inc. is a biotechnology and life sciences company headquartered in Kuala Lumpur, Malaysia. It operates as a fully integrated platform that encompasses biotechnology research, medical services, and wellness solutions, with a specialization in predictive, precision, and preventive health management. Through its subsidiaries, the company provides research and development for advanced therapies, including access to DNA and mRNA sequencing, cellular therapy, and anti-aging products and services. Alps Group Inc. focuses on delivering innovative wellness solutions and medical services tailored to clientele seeking cutting-edge health interventions. Its operations span the biotechnology sector, contributing to advancements in personalized medicine and life sciences applications across regional markets.

United States · https://www.alpinesummitenergy.com